Email This Press Releases

NASDAQ:EIGR Investor Notice Investigation Announced over Potential Wrongdoing at Eiger BioPharmaceuticals, Inc.

Certain directors of Eiger BioPharmaceuticals, Inc are under investigation over potential breaches of fiduciary duties.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy